329 related articles for article (PubMed ID: 26028398)
1. Oral combination therapy in primary care.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 May; 65(5):574-5. PubMed ID: 26028398
[TBL] [Abstract][Full Text] [Related]
2. Diabetes Update: New Pharmacotherapy for Type 2 Diabetes.
Choby B
FP Essent; 2017 May; 456():27-35. PubMed ID: 28530382
[TBL] [Abstract][Full Text] [Related]
3. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.
Ferrannini E; DeFronzo RA
Eur Heart J; 2015 Sep; 36(34):2288-96. PubMed ID: 26063450
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
[TBL] [Abstract][Full Text] [Related]
5. Complementing insulin therapy to achieve glycemic control.
Barnett AH
Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
[TBL] [Abstract][Full Text] [Related]
6. Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.
DeGeeter M; Williamson B
J Pharm Pract; 2016 Apr; 29(2):144-59. PubMed ID: 25312263
[TBL] [Abstract][Full Text] [Related]
7. Clinical decisions. Glycemic management in a patient with type 2 diabetes.
Hirsch IB; Molitch ME
N Engl J Med; 2013 Oct; 369(14):1370-2. PubMed ID: 24088099
[No Abstract] [Full Text] [Related]
8. Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetes.
Home P
Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S33-42. PubMed ID: 22650223
[TBL] [Abstract][Full Text] [Related]
9. Which oral agent to use when metformin is no longer effective?
Bannon M
QJM; 2011 Mar; 104(3):183-4. PubMed ID: 21330402
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease.
Scheen AJ
Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):839-57. PubMed ID: 24669954
[TBL] [Abstract][Full Text] [Related]
11. The backbone of oral glucose-lowering therapy: time for a paradigm shift?
Seufert J
Fundam Clin Pharmacol; 2009 Dec; 23(6):651-67. PubMed ID: 19469803
[TBL] [Abstract][Full Text] [Related]
12. Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis.
Zhang X; Zhao Q
J Hypertens; 2016 Feb; 34(2):167-75. PubMed ID: 26682782
[TBL] [Abstract][Full Text] [Related]
13. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
Inzucchi SE
Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
[No Abstract] [Full Text] [Related]
14. PURLs: Need an add-on to metformin? Consider this.
Wyncott D; Lyon C; Mounsey A
J Fam Pract; 2017 Jan; 66(1):42-44. PubMed ID: 28188318
[TBL] [Abstract][Full Text] [Related]
15. Initiating oral anti diabetic drug: alternatives to metformin.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 Apr; 65(4):440-1. PubMed ID: 25976586
[TBL] [Abstract][Full Text] [Related]
16. China type 2 diabetes treatment status survey of treatment pattern of oral drugs users.
Ji L; Lu J; Weng J; Jia W; Tian H; Zhu D; Xing X; Guo L
J Diabetes; 2015 Mar; 7(2):166-73. PubMed ID: 24809622
[TBL] [Abstract][Full Text] [Related]
17. Drugs for type 2 diabetes.
Med Lett Drugs Ther; 2019 Nov; 61(1584):169-178. PubMed ID: 31770362
[No Abstract] [Full Text] [Related]
18. Metformin and other antidiabetic agents in renal failure patients.
Lalau JD; Arnouts P; Sharif A; De Broe ME
Kidney Int; 2015 Feb; 87(2):308-22. PubMed ID: 24599253
[TBL] [Abstract][Full Text] [Related]
19. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
[No Abstract] [Full Text] [Related]
20. Pharmacological management of type 2 diabetes mellitus: an update.
El-Kaissi S; Sherbeeni S
Curr Diabetes Rev; 2011 Nov; 7(6):392-405. PubMed ID: 21846326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
